Literature DB >> 31425885

Improved protein expression in HEK293 cells by over-expressing miR-22 and knocking-out its target gene, HIPK1.

Sarah Inwood1, Laura Abaandou2, Michael Betenbaugh3, Joseph Shiloach4.   

Abstract

Stable cell lines can continuously produce a recombinant protein without the need to repeatedly engineer the genome. In a previous study HIPK1, Homeodomain-interacting Protein Kinase 1, was found to be a target of the microRNA miR-22 that, when repressed, improved expression of both an intracellular and a secreted protein. In this report, HEK293 cells stably over-expressing miR-22 were compared with HEK293 with knockout of HIPK1, executed by CRISPR/Cas9, for their ability to improve recombinant protein expression. In this model case of luciferase, over-expression of miR-22 improved overall activity 2.4-fold while the HIPK1 knockout improved overall activity 4.7-fold.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CRISPR/Cas9; HIPK1; Protein expression; Stable; miR-22

Mesh:

Substances:

Year:  2019        PMID: 31425885      PMCID: PMC6759407          DOI: 10.1016/j.nbt.2019.08.004

Source DB:  PubMed          Journal:  N Biotechnol        ISSN: 1871-6784            Impact factor:   5.079


  32 in total

Review 1.  microRNAs: tiny regulators with great potential.

Authors:  V Ambros
Journal:  Cell       Date:  2001-12-28       Impact factor: 41.582

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  The microRNA world: small is mighty.

Authors:  Peter Nelson; Marianthi Kiriakidou; Anup Sharma; Elsa Maniataki; Zissimos Mourelatos
Journal:  Trends Biochem Sci       Date:  2003-10       Impact factor: 13.807

Review 4.  Production of recombinant proteins: challenges and solutions.

Authors:  Laura A Palomares; Sandino Estrada-Mondaca; Octavio T Ramírez
Journal:  Methods Mol Biol       Date:  2004

Review 5.  MicroRNAs: tiny targets for engineering CHO cell phenotypes?

Authors:  Niall Barron; Noelia Sanchez; Paul Kelly; Martin Clynes
Journal:  Biotechnol Lett       Date:  2010-09-25       Impact factor: 2.461

6.  Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals.

Authors:  Kyoichi Isono; Kazumi Nemoto; Yuanyuan Li; Yuki Takada; Rie Suzuki; Motoya Katsuki; Akira Nakagawara; Haruhiko Koseki
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

7.  Stable inhibition of mmu-miR-466h-5p improves apoptosis resistance and protein production in CHO cells.

Authors:  Aliaksandr Druz; Young-Jin Son; Michael Betenbaugh; Joseph Shiloach
Journal:  Metab Eng       Date:  2013-01-29       Impact factor: 9.783

8.  HIPK1 interacts with c-Myb and modulates its activity through phosphorylation.

Authors:  Vilborg Matre; Oddmund Nordgård; Anne Hege Alm-Kristiansen; Marit Ledsaak; Odd Stokke Gabrielsen
Journal:  Biochem Biophys Res Commun       Date:  2009-07-30       Impact factor: 3.575

9.  Stable microRNA expression enhances therapeutic antibody productivity of Chinese hamster ovary cells.

Authors:  Michaela Strotbek; Lore Florin; Jennifer Koenitzer; Anne Tolstrup; Hitto Kaufmann; Angelika Hausser; Monilola A Olayioye
Journal:  Metab Eng       Date:  2013-10-18       Impact factor: 9.783

Review 10.  CHO microRNA engineering is growing up: recent successes and future challenges.

Authors:  Vaibhav Jadhav; Matthias Hackl; Aliaksandr Druz; Smriti Shridhar; Cheng-Yu Chung; Kelley M Heffner; David P Kreil; Mike Betenbaugh; Joseph Shiloach; Niall Barron; Johannes Grillari; Nicole Borth
Journal:  Biotechnol Adv       Date:  2013-08-02       Impact factor: 14.227

View more
  1 in total

1.  Functional Verification of the Citrate Transporter Gene in a Wine Lactic Acid Bacterium, Lactiplantibacillus plantarum.

Authors:  Xiangke Yang; Lili Zhao; Qiling Chen; Nan Wang; Kan Shi; Shuwen Liu
Journal:  Front Bioeng Biotechnol       Date:  2022-05-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.